Sophia Genetics (SOPH) said Tuesday it entered into a partnership with biology firm Element Biosciences aiming to combine sequencing and AI analytics to streamline genomic workflows.
The collaboration will integrate Sophia Genetics' AI-powered analytics platform, Sophia DDM, with Element's AVITI24 5D multiomic and AVITI sequencing systems to deliver an end-to-end workflow for next-generation sequencing, the company said.
Shares of Sophia Genetics were 5.8% higher in premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.